258 related articles for article (PubMed ID: 17050558)
1. Statin use is associated with reduced mortality in COPD.
Søyseth V; Brekke PH; Smith P; Omland T
Eur Respir J; 2007 Feb; 29(2):279-83. PubMed ID: 17050558
[TBL] [Abstract][Full Text] [Related]
2. Effect of statin therapy on mortality in patients with peripheral arterial disease and comparison of those with versus without associated chronic obstructive pulmonary disease.
van Gestel YR; Hoeks SE; Sin DD; Simsek C; Welten GM; Schouten O; Stam H; Mertens FW; van Domburg RT; Poldermans D
Am J Cardiol; 2008 Jul; 102(2):192-6. PubMed ID: 18602520
[TBL] [Abstract][Full Text] [Related]
3. Statins may reduce episodes of exacerbation and the requirement for intubation in patients with COPD: evidence from a retrospective cohort study.
Blamoun AI; Batty GN; DeBari VA; Rashid AO; Sheikh M; Khan MA
Int J Clin Pract; 2008 Sep; 62(9):1373-8. PubMed ID: 18422598
[TBL] [Abstract][Full Text] [Related]
4. Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease.
Mancini GB; Etminan M; Zhang B; Levesque LE; FitzGerald JM; Brophy JM
J Am Coll Cardiol; 2006 Jun; 47(12):2554-60. PubMed ID: 16781387
[TBL] [Abstract][Full Text] [Related]
5. Statin use and hospitalization in patients with chronic obstructive pulmonary disease: a nationwide population-based cohort study in Taiwan.
Huang CC; Chan WL; Chen YC; Chen TJ; Chou KT; Lin SJ; Chen JW; Leu HB
Clin Ther; 2011 Oct; 33(10):1365-70. PubMed ID: 21962452
[TBL] [Abstract][Full Text] [Related]
6. Statin use and risk of COPD exacerbation requiring hospitalization.
Wang MT; Lo YW; Tsai CL; Chang LC; Malone DC; Chu CL; Liou JT
Am J Med; 2013 Jul; 126(7):598-606.e2. PubMed ID: 23684060
[TBL] [Abstract][Full Text] [Related]
7. Statins, risk of diabetes, and implications on outcomes in the general population.
Wang KL; Liu CJ; Chao TF; Huang CM; Wu CH; Chen SJ; Chen TJ; Lin SJ; Chiang CE
J Am Coll Cardiol; 2012 Oct; 60(14):1231-8. PubMed ID: 22884288
[TBL] [Abstract][Full Text] [Related]
8. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.
Corrao G; Conti V; Merlino L; Catapano AL; Mancia G
Clin Ther; 2010 Feb; 32(2):300-10. PubMed ID: 20206788
[TBL] [Abstract][Full Text] [Related]
9. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease.
Cyr MC; Beauchesne MF; Lemière C; Aaron SD; Blais L
Ann Pharmacother; 2010 Apr; 44(4):613-22. PubMed ID: 20233915
[TBL] [Abstract][Full Text] [Related]
10. Preinjury statin use is associated with improved in-hospital survival in elderly trauma patients.
Efron DT; Sorock G; Haut ER; Chang D; Schneider E; Mackenzie E; Cornwell EE; Jurkovich GJ
J Trauma; 2008 Jan; 64(1):66-73; discussion 73-4. PubMed ID: 18188101
[TBL] [Abstract][Full Text] [Related]
11. Survival of COPD patients using inhaled corticosteroids and long-acting beta agonists.
Mapel DW; Hurley JS; Roblin D; Roberts M; Davis KJ; Schreiner R; Frost FJ
Respir Med; 2006 Apr; 100(4):595-609. PubMed ID: 16199151
[TBL] [Abstract][Full Text] [Related]
12. Adherence to treatment guidelines and long-term survival in hospitalized patients with chronic obstructive pulmonary disease.
Sarc I; Jeric T; Ziherl K; Suskovic S; Kosnik M; Anker SD; Lainscak M
J Eval Clin Pract; 2011 Aug; 17(4):737-43. PubMed ID: 21223458
[TBL] [Abstract][Full Text] [Related]
13. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.
Lee TA; Wilke C; Joo M; Stroupe KT; Krishnan JA; Schumock GT; Pickard AS
Arch Intern Med; 2009 Aug; 169(15):1403-10. PubMed ID: 19667304
[TBL] [Abstract][Full Text] [Related]
14. Discrepancy between results of randomized control studies and retrospective analysis: the case of statin therapy effect on one-year mortality in patients with decompensated heart failure.
Nevzorov R; Novack V; Henkin Y; Kobal SL; Jotkowitz A; Porath A
Eur J Intern Med; 2009 Sep; 20(5):494-8. PubMed ID: 19712852
[TBL] [Abstract][Full Text] [Related]
15. Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators alone.
Mapel DW; Nelson LS; Lydick E; Soriano J; Yood MU; Davis KJ
COPD; 2007 Jun; 4(2):127-34. PubMed ID: 17530506
[TBL] [Abstract][Full Text] [Related]
16. Statins, systemic inflammation and risk of death in COPD: the Rotterdam study.
Lahousse L; Loth DW; Joos GF; Hofman A; Leufkens HG; Brusselle GG; Stricker BH
Pulm Pharmacol Ther; 2013 Apr; 26(2):212-7. PubMed ID: 23142156
[TBL] [Abstract][Full Text] [Related]
17. Economic assessment of early initiation of inhaled corticosteroids in chronic obstructive pulmonary disease using propensity score matching.
Akazawa M; Biddle AK; Stearns SC
Clin Ther; 2008; 30 Spec No():1003-16. PubMed ID: 18640475
[TBL] [Abstract][Full Text] [Related]
18. Association between incidence of acute exacerbation and medication therapy in patients with COPD.
Suh DC; Lau H; La HO; Choi IS; Geba GP
Curr Med Res Opin; 2010 Feb; 26(2):297-306. PubMed ID: 19961283
[TBL] [Abstract][Full Text] [Related]
19. An epidemiological study of the effects of statin use on airflow limitation in patients with chronic obstructive pulmonary disease.
Bando M; Miyazawa T; Shinohara H; Owada T; Terakado M; Sugiyama Y
Respirology; 2012 Apr; 17(3):493-8. PubMed ID: 22142478
[TBL] [Abstract][Full Text] [Related]
20. Lipid profile and statin use: the paradox of survival after acute exacerbation of chronic obstructive pulmonary disease.
Fruchter O; Yigla M; Kramer MR
Am J Med Sci; 2015 Apr; 349(4):338-43. PubMed ID: 25719977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
